UniProt ID | I2BP1_HUMAN | |
---|---|---|
UniProt AC | Q8IU81 | |
Protein Name | Interferon regulatory factor 2-binding protein 1 | |
Gene Name | IRF2BP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 584 | |
Subcellular Localization | Nucleus . | |
Protein Description | Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities. May act as an E3 ligase towards JDP2, enhancing its polyubiquitination. Represses ATF2-dependent transcriptional activation.. | |
Protein Sequence | MASVQASRRQWCYLCDLPKMPWAMVWDFSEAVCRGCVNFEGADRIELLIDAARQLKRSHVLPEGRSPGPPALKHPATKDLAAAAAQGPQLPPPQAQPQPSGTGGGVSGQDRYDRATSSGRLPLPSPALEYTLGSRLANGLGREEAVAEGARRALLGSMPGLMPPGLLAAAVSGLGSRGLTLAPGLSPARPLFGSDFEKEKQQRNADCLAELNEAMRGRAEEWHGRPKAVREQLLALSACAPFNVRFKKDHGLVGRVFAFDATARPPGYEFELKLFTEYPCGSGNVYAGVLAVARQMFHDALREPGKALASSGFKYLEYERRHGSGEWRQLGELLTDGVRSFREPAPAEALPQQYPEPAPAALCGPPPRAPSRNLAPTPRRRKASPEPEGEAAGKMTTEEQQQRHWVAPGGPYSAETPGVPSPIAALKNVAEALGHSPKDPGGGGGPVRAGGASPAASSTAQPPTQHRLVARNGEAEVSPTAGAEAVSGGGSGTGATPGAPLCCTLCRERLEDTHFVQCPSVPGHKFCFPCSREFIKAQGPAGEVYCPSGDKCPLVGSSVPWAFMQGEIATILAGDIKVKKERDP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASVQASRR ------CCCCCCCCC | 20.57 | - | |
58 | Phosphorylation | AARQLKRSHVLPEGR HHHHHHHHCCCCCCC | 19.16 | 23403867 | |
66 | Phosphorylation | HVLPEGRSPGPPALK CCCCCCCCCCCCCCC | 45.10 | 23927012 | |
73 | Acetylation | SPGPPALKHPATKDL CCCCCCCCCCCHHHH | 50.04 | 25953088 | |
73 | Ubiquitination | SPGPPALKHPATKDL CCCCCCCCCCCHHHH | 50.04 | 29967540 | |
77 | Phosphorylation | PALKHPATKDLAAAA CCCCCCCHHHHHHHH | 29.55 | 21949786 | |
116 | Phosphorylation | QDRYDRATSSGRLPL CCCCCCCCCCCCCCC | 25.07 | 28450419 | |
117 | Phosphorylation | DRYDRATSSGRLPLP CCCCCCCCCCCCCCC | 29.79 | 30576142 | |
118 | Phosphorylation | RYDRATSSGRLPLPS CCCCCCCCCCCCCCC | 24.47 | 28464451 | |
120 | Methylation | DRATSSGRLPLPSPA CCCCCCCCCCCCCHH | 34.77 | 115480483 | |
125 | Phosphorylation | SGRLPLPSPALEYTL CCCCCCCCHHHHHHH | 30.41 | 22617229 | |
130 | Phosphorylation | LPSPALEYTLGSRLA CCCHHHHHHHHHHHH | 14.23 | 22199227 | |
131 | Phosphorylation | PSPALEYTLGSRLAN CCHHHHHHHHHHHHC | 18.44 | 26074081 | |
134 | Phosphorylation | ALEYTLGSRLANGLG HHHHHHHHHHHCCCC | 27.51 | 26074081 | |
157 | Phosphorylation | ARRALLGSMPGLMPP HHHHHHHCCCCCCCH | 23.05 | 28348404 | |
177 | Methylation | AVSGLGSRGLTLAPG HHHCCCCCCCCCCCC | 42.20 | 24129315 | |
180 | Phosphorylation | GLGSRGLTLAPGLSP CCCCCCCCCCCCCCC | 24.57 | 30266825 | |
186 | Phosphorylation | LTLAPGLSPARPLFG CCCCCCCCCCCCCCC | 23.56 | 30266825 | |
189 | Methylation | APGLSPARPLFGSDF CCCCCCCCCCCCCHH | 31.66 | 115480491 | |
194 | Phosphorylation | PARPLFGSDFEKEKQ CCCCCCCCHHHHHHH | 31.62 | 30266825 | |
198 | Ubiquitination | LFGSDFEKEKQQRNA CCCCHHHHHHHHHHH | 70.92 | 33845483 | |
200 | Ubiquitination | GSDFEKEKQQRNADC CCHHHHHHHHHHHHH | 63.90 | - | |
207 | Glutathionylation | KQQRNADCLAELNEA HHHHHHHHHHHHHHH | 3.44 | 22555962 | |
227 | Sumoylation | EEWHGRPKAVREQLL HHHCCCCHHHHHHHH | 59.14 | 28112733 | |
227 | Ubiquitination | EEWHGRPKAVREQLL HHHCCCCHHHHHHHH | 59.14 | - | |
237 | Phosphorylation | REQLLALSACAPFNV HHHHHHHHHHCCEEE | 18.72 | - | |
239 | Glutathionylation | QLLALSACAPFNVRF HHHHHHHHCCEEEEE | 4.43 | 22555962 | |
245 | Methylation | ACAPFNVRFKKDHGL HHCCEEEEECCCCCC | 38.48 | 115387527 | |
247 | Ubiquitination | APFNVRFKKDHGLVG CCEEEEECCCCCCCC | 46.88 | 29967540 | |
248 | Ubiquitination | PFNVRFKKDHGLVGR CEEEEECCCCCCCCE | 52.85 | 29967540 | |
268 | Phosphorylation | ATARPPGYEFELKLF CCCCCCCEEEEEEEE | 24.18 | 17360941 | |
306 | Ubiquitination | DALREPGKALASSGF HHHHCCHHHHHHCCC | 51.44 | 33845483 | |
314 | Ubiquitination | ALASSGFKYLEYERR HHHHCCCCEEEEEHH | 53.07 | 22817900 | |
314 | Sumoylation | ALASSGFKYLEYERR HHHHCCCCEEEEEHH | 53.07 | - | |
314 | Acetylation | ALASSGFKYLEYERR HHHHCCCCEEEEEHH | 53.07 | 26051181 | |
314 | Sumoylation | ALASSGFKYLEYERR HHHHCCCCEEEEEHH | 53.07 | - | |
340 | Phosphorylation | LLTDGVRSFREPAPA HHHHHHHHCCCCCCH | 26.67 | 27251275 | |
354 | Phosphorylation | AEALPQQYPEPAPAA HHHCCCCCCCCCCHH | 12.33 | 26552605 | |
371 | Phosphorylation | GPPPRAPSRNLAPTP CCCCCCCCCCCCCCC | 32.58 | 21712546 | |
377 | Phosphorylation | PSRNLAPTPRRRKAS CCCCCCCCCCCCCCC | 24.66 | 21712546 | |
382 | Sumoylation | APTPRRRKASPEPEG CCCCCCCCCCCCCCC | 51.94 | - | |
382 | Sumoylation | APTPRRRKASPEPEG CCCCCCCCCCCCCCC | 51.94 | - | |
384 | Phosphorylation | TPRRRKASPEPEGEA CCCCCCCCCCCCCCC | 32.60 | 29255136 | |
394 | Ubiquitination | PEGEAAGKMTTEEQQ CCCCCCCCCCHHHHH | 28.48 | 24816145 | |
396 | Phosphorylation | GEAAGKMTTEEQQQR CCCCCCCCHHHHHHH | 34.24 | 29978859 | |
397 | Phosphorylation | EAAGKMTTEEQQQRH CCCCCCCHHHHHHHC | 33.74 | 29978859 | |
412 | Phosphorylation | WVAPGGPYSAETPGV CCCCCCCCCCCCCCC | 24.64 | 30266825 | |
413 | Phosphorylation | VAPGGPYSAETPGVP CCCCCCCCCCCCCCC | 23.82 | 30266825 | |
416 | Phosphorylation | GGPYSAETPGVPSPI CCCCCCCCCCCCCHH | 25.67 | 30266825 | |
421 | Phosphorylation | AETPGVPSPIAALKN CCCCCCCCHHHHHHH | 26.91 | 22167270 | |
427 | Ubiquitination | PSPIAALKNVAEALG CCHHHHHHHHHHHHC | 44.65 | 32015554 | |
436 | Phosphorylation | VAEALGHSPKDPGGG HHHHHCCCCCCCCCC | 31.67 | 29255136 | |
438 | Ubiquitination | EALGHSPKDPGGGGG HHHCCCCCCCCCCCC | 78.54 | 22817900 | |
438 | Sumoylation | EALGHSPKDPGGGGG HHHCCCCCCCCCCCC | 78.54 | 28112733 | |
453 | Phosphorylation | PVRAGGASPAASSTA CCCCCCCCCCCCCCC | 20.53 | 29255136 | |
457 | Phosphorylation | GGASPAASSTAQPPT CCCCCCCCCCCCCCC | 30.26 | 23927012 | |
458 | Phosphorylation | GASPAASSTAQPPTQ CCCCCCCCCCCCCCC | 24.04 | 23927012 | |
458 | O-linked_Glycosylation | GASPAASSTAQPPTQ CCCCCCCCCCCCCCC | 24.04 | 30059200 | |
459 | Phosphorylation | ASPAASSTAQPPTQH CCCCCCCCCCCCCCC | 27.15 | 23927012 | |
459 | O-linked_Glycosylation | ASPAASSTAQPPTQH CCCCCCCCCCCCCCC | 27.15 | 30059200 | |
464 | O-linked_Glycosylation | SSTAQPPTQHRLVAR CCCCCCCCCCCEEEE | 43.63 | 30059200 | |
464 | Phosphorylation | SSTAQPPTQHRLVAR CCCCCCCCCCCEEEE | 43.63 | 26074081 | |
478 | Phosphorylation | RNGEAEVSPTAGAEA ECCCEEECCCCCCCC | 14.19 | 25159151 | |
480 | Phosphorylation | GEAEVSPTAGAEAVS CCEEECCCCCCCCCC | 30.16 | 25159151 | |
487 | Phosphorylation | TAGAEAVSGGGSGTG CCCCCCCCCCCCCCC | 38.48 | 30576142 | |
491 | Phosphorylation | EAVSGGGSGTGATPG CCCCCCCCCCCCCCC | 36.13 | 20068231 | |
493 | Phosphorylation | VSGGGSGTGATPGAP CCCCCCCCCCCCCCC | 25.91 | 28464451 | |
496 | Phosphorylation | GGSGTGATPGAPLCC CCCCCCCCCCCCCEE | 24.49 | 28464451 | |
504 | Phosphorylation | PGAPLCCTLCRERLE CCCCCEEHHHHHHHC | 28.09 | 20068231 | |
536 | Ubiquitination | PCSREFIKAQGPAGE ECCHHHHHHHCCCCE | 39.72 | 32015554 | |
536 | Neddylation | PCSREFIKAQGPAGE ECCHHHHHHHCCCCE | 39.72 | 32015554 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of I2BP1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of I2BP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of I2BP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
JDP2_HUMAN | JDP2 | physical | 18671972 | |
PHS2_HUMAN | PCBD2 | physical | 20211142 | |
IRF2_HUMAN | IRF2 | physical | 12799427 | |
RHG01_HUMAN | ARHGAP1 | physical | 26344197 | |
SYFA_HUMAN | FARSA | physical | 26344197 | |
I2BPL_HUMAN | IRF2BPL | physical | 28514442 | |
I2BP2_HUMAN | IRF2BP2 | physical | 28514442 | |
DCP1B_HUMAN | DCP1B | physical | 28514442 | |
FYB2_HUMAN | C1orf168 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125 AND SER-436, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-186; SER-421;SER-436; SER-453 AND SER-457, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125 AND SER-453, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421; SER-436 ANDSER-453, AND MASS SPECTROMETRY. |